FDA Approved: NABUMETONE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for nabumetone by Chartwell RX, LLC, indicating an additional authorization for this generic drug under ANDA075280.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Nabumetone (Nabumetone)

Snippet

SUPPL AP for NABUMETONE (NABUMETONE)